Your browser doesn't support javascript.
loading
Selective Laser Trabeculoplasty and Outcomes of Subsequent Phacoemulsification Combined with Kahook Dual Blade Goniotomy.
Phillips, Stephen S; Patnaik, Jennifer L; Capitena Young, Cara E; Ertel, Monica K; SooHoo, Jeffrey R; Seibold, Leonard K; Kahook, Malik Y; Pantcheva, Mina B.
Afiliación
  • Phillips SS; Department of Ophthalmology, University of Colorado School of Medicine, Aurora, CO, USA. stephen.phillips@cuanschutz.edu.
  • Patnaik JL; Sue Anschutz-Rodgers Eye Center, 1675 Aurora Court, Aurora, CO, 80045, USA. stephen.phillips@cuanschutz.edu.
  • Capitena Young CE; Department of Ophthalmology, University of Colorado School of Medicine, Aurora, CO, USA.
  • Ertel MK; Department of Ophthalmology, University of Colorado School of Medicine, Aurora, CO, USA.
  • SooHoo JR; Department of Ophthalmology, University of Colorado School of Medicine, Aurora, CO, USA.
  • Seibold LK; Department of Ophthalmology, University of Colorado School of Medicine, Aurora, CO, USA.
  • Kahook MY; Department of Ophthalmology, University of Colorado School of Medicine, Aurora, CO, USA.
  • Pantcheva MB; Department of Ophthalmology, University of Colorado School of Medicine, Aurora, CO, USA.
Ophthalmol Ther ; 11(5): 1883-1893, 2022 Oct.
Article en En | MEDLINE | ID: mdl-35922711
ABSTRACT

INTRODUCTION:

To investigate the relationship between intraocular pressure (IOP)-lowering success of selective laser trabeculoplasty (SLT) and combined phacoemulsification/Kahook Dual Blade (phaco/KDB) goniotomy in eyes with mild to severe open angle glaucoma (OAG).

METHODS:

Eyes undergoing combined phaco/KDB goniotomy and that had previously undergone SLT were analyzed. Data collected included demographics, glaucoma type and severity, IOP, and topical IOP-lowering medications before and after both procedures. Eyes were divided into two groups based on success of SLT, defined as IOP reduction of at least 20% maintained on at least two consecutive follow-up visits without any subsequent medication additions or interventions. Phaco/KDB goniotomy success was defined as IOP reduction of at least 20% and/or reduction in the number of IOP-lowering medications of at least one up to 12 months of follow-up.

RESULTS:

Overall, SLT was successful in 20 of 43 eyes (46.5%), of which 63.6% (7/11) had successful phaco/KDB goniotomy at 12 months follow-up. Among eyes with unsuccessful SLT, 60.0% (9/15) had successful phaco/KDB at 12 months follow-up. Phaco/KDB success rate was similar in patients regardless of their previous response to SLT at all postoperative time points up to 12 months follow-up (p = 0.87).

CONCLUSIONS:

The presence or lack of IOP-lowering response to SLT did not influence the success rate of subsequent phaco/KDB goniotomy in eyes with mild to severe OAG. Patients who did not respond to SLT still benefited from phaco/KDB goniotomy at a later date.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Ophthalmol Ther Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Ophthalmol Ther Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos